Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
One Percent Rule Checklist For Safer Forex Trading Risk 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
NEW YORK, April 21, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased NantHealth, Inc. (NASDAQ:NH) securities (1) pursuant and/or traceable to the Company’s Initial Public Offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/nanthealth-inc-nh?wire=3. There is no cost or obligation to you.
According to the complaint, during the class period the Company made false and/or misleading statements and/or failed to disclose that: (1) Company founder Patrick Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth; (2) as such, the Company and Soon-Shiong participated in the violation of federal tax laws—exposing the Company to possible civil and criminal liability; (3) the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders; and (4) that, as a result, the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016.
If you suffered a loss in NantHealth you have until May 8, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/nanthealth-inc-nh?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
